Skip to main content

Table 4 Clinical response of the 13 patients with increased ANA titer after IFX

From: Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study

  ANA titer EULAR response
  Before After  
1 < 40 80 Good
2 < 40 80 No
3 < 40 640 No
4 < 40 640 No
5 40 160 No
6 40 160 No
7 40 160 Moderate
8 40 320 No
9 40 320 No
10 40 1,280 No
11 80 640 Moderate
12 160 640 No
13 320 1,280 No
  1. ANAs, antinuclear antibodies; IFX, infliximab.